Valance Washington/LinkedIn; Taras Oleksyk/EEBG; Walter Wolfsberger/The Oakland Post
Feb 9, 2026, 14:22
Valance Washington: An Evidence-Based View on Emerging Therapies for Thrombotic Disorders
Valance Washington, Professor at Oakland University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest publication — a letter in the Journal of Thrombosis and Thrombolysis offering an evidence-based view on emerging therapies for thrombotic disorders.
A quick read for clinicians and researchers navigating these challenges.”
Title: Subject: letter to the editor: platelet single-cell RNA sequencing
Authors: Valance Washington, Walter Wolfsberger, Taras Oleksyk
Read the Full Article on Journal of Thrombosis and Thrombolysis
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 2, 2026, 19:40Minoo Ahmadinejad: Improving the Recognition of Women and Girls With Hemophilia
-
Jul 2, 2026, 19:26Dhinesh Selvaraju: FDA Expands Access to HYMPAVZI in Hemophilia
-
Jul 2, 2026, 19:13Syed Fahad Hussain: Not Every Low Platelet Count Tells the Same Story
-
Jul 2, 2026, 18:59Indu Thakur: Supporting Blood Donation Through Public Awareness in MSBT
-
Jul 2, 2026, 18:47Vee Townsend: IMHUE Highlights 9 Myths and Facts About Hemophilia B
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association